16-88805795-G-A

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_030928.4(CDT1):​c.758G>A​(p.Arg253His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000196 in 1,613,146 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R253C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00077 ( 0 hom., cov: 35)
Exomes 𝑓: 0.00014 ( 0 hom. )

Consequence

CDT1
NM_030928.4 missense

Scores

1
7
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 2.74

Publications

1 publications found
Variant links:
Genes affected
CDT1 (HGNC:24576): (chromatin licensing and DNA replication factor 1) The protein encoded by this gene is involved in the formation of the pre-replication complex that is necessary for DNA replication. The encoded protein can bind geminin, which prevents replication and may function to prevent this protein from initiating replication at inappropriate origins. Phosphorylation of this protein by cyclin A-dependent kinases results in degradation of the protein. [provided by RefSeq, Mar 2011]
CDT1 Gene-Disease associations (from GenCC):
  • Meier-Gorlin syndrome 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • Meier-Gorlin syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.013385385).
BP6
Variant 16-88805795-G-A is Benign according to our data. Variant chr16-88805795-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 434675.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000768 (117/152326) while in subpopulation AFR AF = 0.00224 (93/41566). AF 95% confidence interval is 0.00187. There are 0 homozygotes in GnomAd4. There are 55 alleles in the male GnomAd4 subpopulation. Median coverage is 35. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_030928.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDT1
NM_030928.4
MANE Select
c.758G>Ap.Arg253His
missense
Exon 5 of 10NP_112190.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDT1
ENST00000301019.9
TSL:1 MANE Select
c.758G>Ap.Arg253His
missense
Exon 5 of 10ENSP00000301019.4
CDT1
ENST00000569140.1
TSL:3
c.26G>Ap.Arg9His
missense
Exon 1 of 5ENSP00000456926.1
CDT1
ENST00000562747.1
TSL:2
n.464G>A
non_coding_transcript_exon
Exon 4 of 5

Frequencies

GnomAD3 genomes
AF:
0.000769
AC:
117
AN:
152208
Hom.:
0
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.00224
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00169
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000372
AC:
93
AN:
249804
AF XY:
0.000317
show subpopulations
Gnomad AFR exome
AF:
0.00261
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000545
Gnomad FIN exome
AF:
0.00158
Gnomad NFE exome
AF:
0.0000266
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.000136
AC:
199
AN:
1460820
Hom.:
0
Cov.:
69
AF XY:
0.000139
AC XY:
101
AN XY:
726692
show subpopulations
African (AFR)
AF:
0.00254
AC:
85
AN:
33476
American (AMR)
AF:
0.0000894
AC:
4
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.000151
AC:
6
AN:
39698
South Asian (SAS)
AF:
0.000186
AC:
16
AN:
86250
European-Finnish (FIN)
AF:
0.00124
AC:
65
AN:
52466
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.00000809
AC:
9
AN:
1111940
Other (OTH)
AF:
0.000232
AC:
14
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
14
28
42
56
70
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000768
AC:
117
AN:
152326
Hom.:
0
Cov.:
35
AF XY:
0.000738
AC XY:
55
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.00224
AC:
93
AN:
41566
American (AMR)
AF:
0.000196
AC:
3
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00169
AC:
18
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68028
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
6
12
19
25
31
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000267
Hom.:
0
Bravo
AF:
0.000839
ESP6500AA
AF:
0.00250
AC:
11
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000297
AC:
36

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 24, 2017
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CDT1-related disorder Benign:1
May 09, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

not provided Benign:1
Jul 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.40
CADD
Uncertain
24
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.18
T
Eigen
Uncertain
0.22
Eigen_PC
Benign
0.10
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Uncertain
0.87
D
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.013
T
MetaSVM
Benign
-0.94
T
MutationAssessor
Uncertain
2.6
M
PhyloP100
2.7
PrimateAI
Benign
0.26
T
PROVEAN
Uncertain
-3.3
D
REVEL
Benign
0.15
Sift
Uncertain
0.027
D
Sift4G
Uncertain
0.019
D
Polyphen
1.0
D
Vest4
0.17
MVP
0.66
MPC
0.016
ClinPred
0.062
T
GERP RS
2.8
PromoterAI
-0.011
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.11
gMVP
0.41
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148337159; hg19: chr16-88872203; API